Change in Directors/KMP
Venkys Appoints Two Additional Directors
Venkys (India) appointed Col (Dr) Ram Vasant Athavale as an Independent Director and Brig. Ashutosh Dattaray Nargolkar as a Non-Executive Director, subject to shareholder approval.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
7
Bullish
3
Bearish
34
Neutral
7
Bullish
5
Bearish
30
Neutral
0
Bullish
2
Bearish
30
Neutral
0
Bullish
2
Bearish
30
Neutral
0
Bullish
2
Bearish
30
Neutral
0
Bullish
2
Upcoming Result Date: Today
View Standalone
View Standalone
Change in Directors/KMP
Venkys (India) appointed Col (Dr) Ram Vasant Athavale as an Independent Director and Brig. Ashutosh Dattaray Nargolkar as a Non-Executive Director, subject to shareholder approval.
Financial Results
Venky's (India) Limited reported audited financial results for the quarter and half year ended 30 September 2026, with quarterly profit of 1,461 compared with a loss of 2,653 a year earlier.
Food Products
Meat Products including Poultry
2,178 Cr
Moderate Risk
12.6
39.8
0.5
1.4
1,815.80
1,166.05
Sales CAGR
Profit CAGR
ROE
ROCE

Venkys (India) Ltd (VENKEYS) is currently trading at 1,546.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Venky's (India) Limited is an integrated poultry and agri‑processing company operating breeding, hatcheries, processed chicken, SPF eggs, animal health products, feed and oilseed processing across India; it sits within the VH Group and supplies both internal group needs and external markets through branded and B2B channels. Q4/FY26 delivered visible operating momentum: commercial broiler realization in Q4 averaged INR102.67/kg, day‑old broiler chicks averaged INR51.32, and the Animal Health division achieved near‑term annual sales of ~INR100 crore with quarterly EBIT margins around 29%, a material improvement versus historical mid‑20s margins. The oilseed/solvent extraction business has meaningfully recovered capacity utilization (around 65–70% in Q4) and posted higher profitability (Q4 EBIT ~5.3%); management is targeting ~80% utilization, a higher share of outside sales (targeting ~33% meal outside the group), and consistent commodity conversion margins rather than speculative volume swings. Operational balance-sheet strength underpins the strategy: management highlights no near‑term incremental leverage for procurement, working capital availability near INR160 crore, receivables around INR544 crore, and debt‑free positioning in parts of the oilseed business, allowing focus on utilization and margin improvement. Key near‑term risks include feed ingredient price volatility linked to crude/ethanol dynamics, seasonal productivity reduction in Q1 due to heat, and a group‑level CCI notice that management says does not materially affect the listed entity today; management emphasizes an annual, not quarterly, performance focus and anticipates industry growth of 7–8%.
Over the past 52 weeks, Venkys (India) Ltd has traded between a low of ₹1,166.05 and a high of ₹1,815.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Venkys (India) Ltd has a market capitalization of approximately 2,271.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Venkys (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 13.10 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,271.86 Cr, Venkys (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Venkys (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Venkys (India) Ltd is 13.10. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Venky's reported basic and diluted earnings per share of Rs 10.37 for the quarter ended 30 September 2026. This compared with negative Rs 18.83 in the September 2025 quarter and Rs 35.49 in the June 2026 quarter.
Venky's poultry and poultry products business recorded profit before tax and interest of Rs 10.12 crore for the quarter ended 30 September 2026. In the corresponding quarter of 2025, the segment had reported a Rs 58.31 crore loss. Management linked the improvement to operating efficiency and better realisations.
Venky's reported a net decrease of Rs 61.03 crore in cash and cash equivalents during the half year ended 30 September 2026. A Rs 110.64 crore operating cash outflow was only partly offset by Rs 50.12 crore generated from investing activities.
Venky's (India) is scheduled to announce Q2 FY27 results on 13 November 2026. The board is expected to approve the July-September 2026 quarterly results and H1 FY27 audited results that day.